Taxotere linked thousands of lawsuits were centralized in October 2016 under MDL No. 2740 (in re Taxotere (Docetaxel) Products Liability Litigation) before Judge Kurt D. Engelhardt in the Eastern District of Louisiana; four cases have been selected to be a part of the first series of bellwether trials to begin in September.
With the mounting number of similar claims in New Jersey, a request for a centralized management has been requested by hundreds of women who filed their cases in New Jersey alleging that Sanofi-Aventis, the makers of the chemotherapy drug, failed to adequately warn consumers about the risk of permanent hair loss from using the breast cancer drug Taxotere.
